2020-07-08 22:07:00| Fool.com Headlines
The animal health company's reliance on livestock has proved a risk during an uncertain year. Can a massive acquisition change that?
2020-07-08 20:41:00| Fool.com Headlines
One of the best investments of 2019 fell on hard times in the first six months of 2020, but it's not as bad as it seems.
2020-07-08 20:18:00| Fool.com Headlines
The pharma giant missed an opportunity for growth as breast cancer treatment Ibrance failed a key clinical trial.
2020-07-08 15:21:00| Fool.com Headlines
With almost all stores reopened since the pandemic broke out, the coffee giant is seeing a slow but steady recovery.
2020-07-02 22:51:51| Fool.com Headlines
A patent ruling involving Biogens blockbuster drug weighed on share performance.